EGFR Gene Signature May Predict Prognosis and Guide Treatment in Lung Cancer
EGFR Gene Signature May Predict Prognosis and Guide Treatment in Lung Cancer
Oncogenically mutated epidermal growth-factor receptor (EGFR) is a validated therapeutic target for nonsmall-cell lung cancer (NSCLC). Researchers now report that they have identified a 93-gene signature that is significantly associated with EGFR mutations in NSCLC patients.
The study results suggest that the gene signature might [...]